Smoothened Agonist Reduces Human Immunodeficiency Virus Type-1-Induced Blood-Brain Barrier Breakdown in Humanized Mice
Vir B. Singh(University of Rochester Medical Center), Sanjay B. Maggirwar(University of Rochester Medical Center)
Cited by 51
Related Papers
Inhibition of Mixed Lineage Kinase 3 Prevents HIV-1 Tat-Mediated Neurotoxicity and Monocyte Activation
|The Journal of Immunology|2006|51
Antiplatelet Activity of Valproic Acid Contributes to Decreased Soluble CD40 Ligand Production in HIV Type 1-Infected Individuals
|The Journal of Immunology|2010|37
Ibudilast, a Pharmacologic Phosphodiesterase Inhibitor, Prevents Human Immunodeficiency Virus-1 Tat-Mediated Activation of Microglial Cells
|PLoS ONE|2011|31